Production (Stage)
Regen BioPharma, Inc.
RGBP
$0.0632
-$0.0068-9.71%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -85.71% | -98.87% | -20.87% | -37.27% | 2.89% |
| Total Receivables | 28.87% | 41.43% | 69.02% | 222.76% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -20.22% | 174.79% | 350.00% | 4.00% | -50.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.63% | 4.92% | 23.90% | -13.26% | 8.24% |
|
|
|||||
| Total Current Assets | 8.63% | 4.92% | 23.90% | -13.26% | 8.24% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.77% | 4.35% | 20.88% | -11.72% | -54.89% |
|
|
|||||
| Total Accounts Payable | 21.21% | 1.02% | -1.34% | -32.58% | 48.82% |
| Total Accrued Expenses | 2.58% | 0.15% | 1.07% | -1.08% | 1.08% |
| Short-term Debt | -63.53% | 34.49% | 336.65% | 0.00% | -48.09% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 48.95% | 0.00% | 0.00% | -1.96% | 0.00% |
| Total Finance Division Other Current Liabilities | 13.61% | -1.19% | -1.06% | -1.06% | -1.55% |
| Total Other Current Liabilities | 13.61% | -1.19% | -1.06% | -1.06% | -1.55% |
| Total Current Liabilities | 9.29% | 0.82% | 2.99% | -1.41% | -1.15% |
|
|
|||||
| Total Current Liabilities | 9.29% | 0.82% | 2.99% | -1.41% | -1.15% |
| Long-Term Debt | -- | -- | -- | -6.69% | 2.94% |
| Short-term Debt | -63.53% | 34.49% | 336.65% | 0.00% | -48.09% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.29% | 0.82% | 0.21% | -1.56% | -1.04% |
|
|
|||||
| Common Stock & APIC | 0.23% | 1.50% | 0.99% | 1.27% | 1.45% |
| Retained Earnings | -1.53% | -1.30% | -0.64% | -0.61% | -1.77% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -9.34% | -0.72% | 0.35% | 1.25% | -2.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.34% | -0.72% | 0.35% | 1.25% | -2.69% |
| Total Preferred Equity | 0.00% | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.34% | -0.70% | 0.35% | 1.25% | -2.69% |
|
|
|||||